We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

159 hedge funds and large institutions have $1.13B invested in Cardiovascular Systems, Inc. in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 46 increasing their positions, 52 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

169% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 13

23% more capital invested

Capital invested by funds: $914M → $1.13B (+$213M)

16% more funds holding

Funds holding: 137159 (+22)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

12% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 52

51% less call options, than puts

Call options by funds: $1.1M | Put options by funds: $2.24M

Holders
159
Holders Change
+22
Holders Change %
+16.06%
% of All Funds
3.64%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
35
Increased
46
Reduced
52
Closed
13
Calls
$1.1M
Puts
$2.24M
Net Calls
-$1.14M
Net Calls Change
-$1.28M
Name Holding Trade Value Shares
Change
Change in
Stake
GKIM
26
GW&K Investment Management
Massachusetts
$9.37M -$221K -5,971 -2%
Citadel Advisors
27
Citadel Advisors
Florida
$9.26M +$4.73M +127,848 +118%
Fuller & Thaler Asset Management
28
Fuller & Thaler Asset Management
California
$8.77M +$8.28M +223,966 New
Morgan Stanley
29
Morgan Stanley
New York
$8.65M +$2.86M +77,458 +54%
Man Group
30
Man Group
United Kingdom
$8.19M +$2.41M +65,078 +45%
GF
31
Gabelli Funds
New York
$8.02M -$924K -25,000 -11%
TAM
32
THB Asset Management
Connecticut
$7.34M +$72.4K +1,959 +1%
Charles Schwab
33
Charles Schwab
California
$7.13M +$399K +10,798 +6%
CM
34
Castleark Management
Illinois
$6.73M +$6.36M +172,030 New
SCA
35
Secor Capital Advisors
New York
$6.62M +$2.35M +63,506 +60%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$5.8M -$108K -2,930 -2%
Jacobs Levy Equity Management
37
Jacobs Levy Equity Management
New Jersey
$5.65M +$590K +15,963 +12%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$5.59M +$1.37M +37,000 +35%
Thrivent Financial for Lutherans
39
Thrivent Financial for Lutherans
Minnesota
$5.45M -$620K -16,783 -11%
First Manhattan
40
First Manhattan
New York
$5.33M
Arrowstreet Capital
41
Arrowstreet Capital
Massachusetts
$5.23M +$4.94M +133,647 New
Russell Investments Group
42
Russell Investments Group
United Kingdom
$4.79M +$2.28M +61,572 +101%
TA
43
Teton Advisors
New York
$4.35M
USAA
44
United Services Automobile Association
Texas
$4.27M
QI
45
QS Investors
New York
$3.44M +$1.55K +42 +0%
Bank of America
46
Bank of America
North Carolina
$3.38M +$2.92M +78,927 +1,046%
GI
47
GAMCO Investors
Connecticut
$3.29M -$142K -3,850 -4%
AQR Capital Management
48
AQR Capital Management
Connecticut
$3M +$882K +23,864 +45%
MPI
49
Mairs & Power Inc
Minnesota
$2.97M -$192K -5,200 -6%
Ameriprise
50
Ameriprise
Minnesota
$2.9M -$166K -4,479 -6%

CSII Hedge Fund Activity: Q3 2018 in Review

159 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2018, worth a combined $1.13B — up 23% from $914M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new CSII positions and 13 closed out — a net gain of 22 holders — while 46 added to existing stakes and 52 trimmed.

The largest buyer was Brown Capital Management, adding an estimated $22.3M. The largest seller was Camber Capital Management, exiting entirely with an estimated $53.3M sold.

  • 159 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2018, up from 137 in Q2 2018.
  • Funds reported $1.13B of Cardiovascular Systems, Inc. stock for Q3 2018, up 23% quarter-over-quarter.
  • 35 funds opened new Cardiovascular Systems, Inc. positions in Q3 2018 and 13 closed out, a net change of +22 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2018 was Brown Capital Management, an estimated $22.3M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2018 was Camber Capital Management, an estimated $53.3M sold.

Based on aggregated 13F filings for Q3 2018.